Long‐term Outcomes of Salvage Radiotherapy Using TomoTherapy With Image‐guided Radiotherapy for Postoperative Prostate Cancer Patients
Our findings demonstrate a comparable PFR at 5-year (69.05%) and 10-year (54.73%) intervals with those of previous reports, confirming the efficacy of IMRT-IGRT as a viable option for SRT. Worse PFR was associated with factors such as mass PSA >0.7 ng/ml, providing critical insights into prognostication. SRT for prostate cancer with IMRT and IGRT using TomoTherapy showed similar treatment outcomes and low toxicity rates compared with those of previous studies.
Authors
- Yuki Mukai (ORCID: https://orcid.org/0000-0002-0000-1199)
- Motoko Omura (ORCID: https://orcid.org/0000-0002-1344-0588)
- Misato Mase
- Ichiro Miura
- Yuta Nishikawa
- Yumiko Minagawa
- Masaharu Hata (ORCID: https://orcid.org/0000-0002-4133-2592)
Institutions
- Yokohama City University Medical Center (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-03-01
- DOI
- https://doi.org/10.21873/cdp.10429
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52